Poster presentation of interim results from the Phase 2 study of the GBM treatment (OKN-007) at the AACR 2024

Sole contract for public COVID-19 vaccine distribution and nationwide cold chain infrastructure development

Phase 1 clinical trial of the oral formulation of the GBM treatment (OKN-007) underway

Changed company name to HLB Therapeutics Co., Ltd.

Completed merger with YS Pharm Co., Ltd.

Phase 3 clinical study protocol (ARISE-3) protocol for the treatment of dry eye syndrome (RGN-259) accepted by the US

Acquired an additional stake in ReGenTree, LLC (61.5%)

Phase 1 clinical study protocol for combination therapy with OKN-007 and temozolomide in patients with newly diagnosed glioblastoma accepted by the US FDA as an investigator initiated trial agreed by the US FDA

Phase 3 clinical study (ARISE-2) protocol for Dry Eye Syndrome (RGN-259) accepted by the US FDA

Obtained designation of OKN-007 as orphan drug by the US FDA for a treatment of glioblastoma multiforme

Acquired the development pipeline, OKN-007, for the treatment of Glioblastoma from OMRF

Established Oblato, Inc., a wholly owned subsidiary in the United States

Phase 2b/3 clinical study (ARISE-1) protocol for Dry Eye Syndrome (RGN-259) accepted by the US FDA

Phase 3 clinical study (SEER-1) protocol for neurotrophic keratitis (RGN-259) accepted by the US FDA

Obtained IND approval by Korea Food and Drug Administration for Phase 2b/3 clinical study protocol of Dry Eye Syndrome (GBT-201)

Established ReGenTree, LLC, a US joint venture

Changed company name to GtreeBNT Co., Ltd.

Executed license agreements of new drug development pipelines, RGN-259 and RGN-137, with RegeneRx Biopharmaceuticals, Inc., a US Biotech company

RGN-259 designated as orphan drug by the US FDA for a treatment of neurotrophic keratitis

Merged with Coreindus Co., Ltd.

Merged with The Change Co., Ltd.

Listed on the KOSDAQ

Awarded the Prime Minister Award as the ‘2008 Venture Business

Moved headquarters to new location

Awarded the ‘2007 Seongnam Small and Medium Venture Business Award’

Established Digital Aria Co., Ltd. as a company